In PTCLs, Rac1 plays a prominent role in ALK+ALCL subtype where it is often hyperactivated and involved in the oncogenic program triggered by the NPM-ALK signaling (51, 52) (this aspect will be discussed in details in the next paragraph). Here, RAC1 is linked to anaplastic large cell lymphoma.